| pubmed-article:272395 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:272395 | lifeskim:mentions | umls-concept:C0016030 | lld:lifeskim |
| pubmed-article:272395 | lifeskim:mentions | umls-concept:C0031507 | lld:lifeskim |
| pubmed-article:272395 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:272395 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:272395 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:272395 | pubmed:dateCreated | 1978-4-17 | lld:pubmed |
| pubmed-article:272395 | pubmed:abstractText | It was found that 0.02 mM was the higher concentration of drug which is not toxic and is compatible with normal cell morphology and growth over a period of a week. Using this concentration of drug there was no consistent stimulation of cell growth. A small increase in cell number was noted, however, in some cultures during the first 24 hours of culture. DpH at a concentration of 0.02 mM in the presence of ascorbic acid decreased collagen prolyl hydroxylation in "old" W1-38 cultures but a concentration of 0.1 mM was required to decrease the values to a similar extent in "young" cultures. A concentration of 0.02 mM DpH had no effect on hydroxylation in an "old" HGF culture. It is speculated that in a responsive individual a reduction of collagen prolyl hydroxylation may play a role in the etiology of DpH-induced gingival enlargement and congenital malformations. | lld:pubmed |
| pubmed-article:272395 | pubmed:language | eng | lld:pubmed |
| pubmed-article:272395 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:272395 | pubmed:citationSubset | D | lld:pubmed |
| pubmed-article:272395 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:272395 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:272395 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:272395 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:272395 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:272395 | pubmed:issn | 0022-0345 | lld:pubmed |
| pubmed-article:272395 | pubmed:author | pubmed-author:GallopP MPM | lld:pubmed |
| pubmed-article:272395 | pubmed:author | pubmed-author:PazM AMA | lld:pubmed |
| pubmed-article:272395 | pubmed:author | pubmed-author:da Keith | lld:pubmed |
| pubmed-article:272395 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:272395 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:272395 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:272395 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:272395 | pubmed:pagination | 1279-83 | lld:pubmed |
| pubmed-article:272395 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:272395 | pubmed:meshHeading | pubmed-meshheading:272395-H... | lld:pubmed |
| pubmed-article:272395 | pubmed:meshHeading | pubmed-meshheading:272395-C... | lld:pubmed |
| pubmed-article:272395 | pubmed:meshHeading | pubmed-meshheading:272395-P... | lld:pubmed |
| pubmed-article:272395 | pubmed:meshHeading | pubmed-meshheading:272395-P... | lld:pubmed |
| pubmed-article:272395 | pubmed:meshHeading | pubmed-meshheading:272395-F... | lld:pubmed |
| pubmed-article:272395 | pubmed:meshHeading | pubmed-meshheading:272395-C... | lld:pubmed |
| pubmed-article:272395 | pubmed:meshHeading | pubmed-meshheading:272395-H... | lld:pubmed |
| pubmed-article:272395 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:272395 | pubmed:articleTitle | The effect of diphenylhydantoin on fibroblasts in vitro. | lld:pubmed |
| pubmed-article:272395 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:272395 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:272395 | lld:pubmed |
